SCHEMBL6998519

SCHEMBL6998519

O=C(O)Oc1cc(=O)n(-c2ccccc2)c2ccccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 1/20 0.47
KDM4E B2RXH2 2/20 0.46
ATM Q13315 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
HTR3E A5X5Y0 2/20 0.46
HTR3B O95264 2/20 0.46
HTR3A P46098 2/20 0.46
HTR3D Q70Z44 2/20 0.46
HTR3C Q8WXA8 2/20 0.46
ALDH1A1 P00352 4/20 0.43
MAPT P10636 3/20 0.43
PKM P14618 1/20 0.43
KMT2A Q03164 3/20 0.42
RECQL P46063 1/20 0.41
TSHR P16473 2/20 0.40
MEN1 O00255 2/20 0.40
MTNR1A P48039 1/20 0.40
MTNR1B P49286 1/20 0.40
POLB P06746 1/20 0.40
BRCA1 P38398 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11540274 0.88 NPSR1 (0.47) KDRKDM4EATML3MBTL1HTR3E
SCHEMBL12641988 0.87 HCRTR1 (0.49) KDRKDM4EATML3MBTL1HTR3E
SCHEMBL11540070 0.78 NPSR1 (0.46) KDM4EHTR3EHTR3BHTR3AHTR3D
SCHEMBL11542615 0.78 NPSR1 (0.46) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL11541055 0.78 NPSR1 (0.46) KDM4EHTR3EHTR3BHTR3AHTR3D
SCHEMBL11544638 0.77 THRB (0.45) KDM4EALDH1A1MAPTPKMKMT2A
SCHEMBL11538165 0.77 NPSR1 (0.51) KDM4EMAPTKMT2AMEN1POLB
SCHEMBL7433737 0.76 HTR3E (0.54) KDRKDM4EATML3MBTL1HTR3E
SCHEMBL11540447 0.76 POLB (0.45) KDM4EALDH1A1MAPTKMT2AMEN1
SCHEMBL11575819 0.76 HTT (0.40) KDM4EATMHTR3EHTR3BHTR3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1003724-B1 SUBSTITUTED QUINOLINE DERIVATIVES WITH ANTIVIRAL ACTION AVENTIS PHARMA GMBH (DE) 2003-02-12 EP disclosed
EP-1003724-A1 SUBSTITUTED QUINOLINE DERIVATIVES WITH ANTIVIRAL ACTION Aventis Pharma Deutschland GmbH (DE) 2000-05-31 EP disclosed
WO-1997037977-A1 SUBSTITUTED QUINOLINE DERIVATIVES WITH ANTIVIRAL ACTION HOECHST AKTIENGESELLSCHAFT (DE) 1997-10-16 WO disclosed